Literature DB >> 6360002

Staphylococcus epidermidis infections.

F D Lowy, S M Hammer.   

Abstract

Staphylococcus epidermidis, an organism routinely found on the skin and in the hospital environment, has become a primary pathogen in infections associated with prosthetic devices. Because these infections are indolent and often clinically silent, diagnosis and therapy are often difficult. Pathogens are often misidentified as contaminants. Their variable, often resistant antibiotic susceptibility pattern and the uncertain correlation of in-vitro beta-lactam sensitivity testing with therapeutic efficacy make selection of an effective antibiotic regimen difficult. Vancomycin combined with rifampin, gentamicin, or both, is recommended for empiric therapy of these infections. Usually, removal of the prosthetic device is also necessary and may contribute equally to a successful therapeutic outcome.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6360002     DOI: 10.7326/0003-4819-99-6-834

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  56 in total

Review 1.  Recurrent Staphylococcus warnerii prosthetic valve endocarditis: a case report and review.

Authors:  Ferhat Arslan; Nese Saltoglu; Birgül Mete; Ali Mert
Journal:  Ann Clin Microbiol Antimicrob       Date:  2011-04-23       Impact factor: 3.944

2.  Differential production of slime under aerobic and anaerobic conditions.

Authors:  L P Barker; W A Simpson; G D Christensen
Journal:  J Clin Microbiol       Date:  1990-11       Impact factor: 5.948

3.  Species-level identification of staphylococcal isolates by real-time PCR and melt curve analysis.

Authors:  Aine Skow; Kathy A Mangold; Mohammed Tajuddin; Anne Huntington; Brett Fritz; Richard B Thomson; Karen L Kaul
Journal:  J Clin Microbiol       Date:  2005-06       Impact factor: 5.948

4.  Nonproduction of toxic shock syndrome toxin 1 by coagulase-negative staphylococci.

Authors:  J Parsonnet; A E Harrison; S E Spencer; A Reading; K C Parsonnet; E H Kass
Journal:  J Clin Microbiol       Date:  1987-08       Impact factor: 5.948

5.  Immunochemical analysis of the extracellular slime substance of Staphylococcus epidermidis.

Authors:  P Kotilainen; J Mäki; P Oksman; M K Viljanen; J Nikoskelainen; P Huovinen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-04       Impact factor: 3.267

6.  In vitro susceptibilities of four species of coagulase-negative staphylococci.

Authors:  R J Fass; V L Helsel; J Barnishan; L W Ayers
Journal:  Antimicrob Agents Chemother       Date:  1986-10       Impact factor: 5.191

7.  Staphylococcus simulans septicemia in a patient with chronic osteomyelitis and pyarthrosis.

Authors:  B M Males; W R Bartholomew; D Amsterdam
Journal:  J Clin Microbiol       Date:  1985-02       Impact factor: 5.948

8.  Effect of vancomycin hydrochloride on Staphylococcus epidermidis biofilm associated with silicone elastomer.

Authors:  R C Evans; C J Holmes
Journal:  Antimicrob Agents Chemother       Date:  1987-06       Impact factor: 5.191

9.  In vitro activities of two oxazolidinone antimicrobial agents, DuP 721 and DuP 105.

Authors:  H C Neu; A Novelli; G Saha; N X Chin
Journal:  Antimicrob Agents Chemother       Date:  1988-04       Impact factor: 5.191

Review 10.  Current problems of chemotherapy of infections with coagulase-negative staphylococci.

Authors:  A J Davies; J W Stone
Journal:  Eur J Clin Microbiol       Date:  1986-06       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.